TFFP Company Profile and Key Details
TFF Pharmaceuticals, Inc.
TFFP Stock Price Chart
Stock Price Today
TFF Pharmaceuticals, Inc. (TFFP) stock declined over -60.05%, trading at $0.07 on NASDAQ, down from the previous close of $0.16. The stock opened at $0.09, fluctuating between $0.06 and $0.09 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company's lead drug candidates are TFF Voriconazole Inhalation Powder, which is in Phase II clinical trials for the treatment of invasive pulmonary aspergillosis; and TFF Tacrolimus Inhalation Powder, which is in Phase II clinical trials used to prevent lung transplant rejection. It is also developing other dry powder products, such as cannabidiol substance for the treatment of various epilepsy syndromes, as well as anxiety, insomnia, and various pain; Inhaled SARS-CoV2 Monoclonal Antibody for the treatment of patients with COVID-19 infections; Niclosamide Inhalation Powder to treat tapeworm infections in humans, as well as COVID-19 disease; and other vaccines. The company has a license agreement with the University of Texas at Austin for the development of inhaled dry powder drugs; a joint development agreement with Augmenta Bioworks, Inc. to develop inhaled SARS-CoV2 monoclonal antibody; and a licensing and collaboration agreement with UNION therapeutics A/S. The company was incorporated in 2018 and is based in Austin, Texas.
Company Information
| Employees | 19 |
| Beta | 1.32 |
| Sales or Revenue | $733.87K |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) stock price is $0.07 in the last trading session. During the trading session, TFFP stock reached the peak price of $0.09 while $0.06 was the lowest point it dropped to. The percentage change in TFFP stock occurred in the recent session was -60.05% while the dollar amount for the price change in TFFP stock was -$0.10.
The NASDAQ listed TFFP is part of Biotechnology industry that operates in the broader Healthcare sector. TFF Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Harlan F. Weisman
Interim Chief Executive Officer & Pres and Vice Chairman
Dr. Dale Christensen Ph.D.
Head of Clinical Devel.
Dr. Zamaneh Mikhak M.D.
Chief Medical Officer
Mr. Kirk Allen Coleman
Chief Financial Officer, Treasurer & Sec.
Mr. Glenn R. Mattes
Pres, Chief Executive Officer & Director
Mr. Paul F. Manley
Head of Regulatory Affairs
Mr. Christopher Cano
Chief Operating Officer & Vice President of Bus. Devel.
Dr. Anthony J. Hickey Ph.D.
Chief Scientific Officer
TFFP's closing price is 6.56% higher than its 52-week low of $0.06 where as its distance from 52-week high of $11.00 is -99.41%.
Number of TFFP employees currently stands at 19.
Official Website of TFFP is: https://www.tffpharma.com
TFFP could be contacted at phone 817 438 6168 and can also be accessed through its website. TFFP operates from 1751 River Run, Austin, TX 76107, United States.
TFFP stock volume for the day was 11.02M shares. The average number of TFFP shares traded daily for last 3 months was 1.72M.
The market value of TFFP currently stands at $288.80K with its latest stock price at $0.07 and 4.44M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com